A prospective, randomized study on hepatotoxicity of anastrozole compared with tamoxifen in women with breast cancer

Tamoxifen and anastrozole are widely used as adjuvant treatment for early stage breast cancer, but their hepatotoxicity is not fully defined. We aimed to compare hepatotoxicity of anastrozole with tamoxifen in the adjuvant setting in postmenopausal breast cancer patients. Three hundred and fifty-thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ying, Liu, Jianlun, Zhang, Xiaohua, Li, Li, Hu, Rui, Liu, Jian, Deng, Yongchuan, Chen, Dedian, Zhao, Yangbing, Sun, Shengrong, Ma, Rong, Zhao, Ying, Liu, Jinping, Zhang, Yang, Wang, Xijing, Li, Yafen, He, Pingqing, Li, Enxiao, Xu, Zheli, Wu, Yaqun, Tong, Zhongsheng, Wang, Xiaojia, Huang, Tao, Liang, Zhongxiao, Wang, Shui, Su, Fengxi, Lu, Yunfei, Zhang, Helong, Feng, Guosheng, Wang, Shenming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462391/
https://www.ncbi.nlm.nih.gov/pubmed/24975596
http://dx.doi.org/10.1111/cas.12474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462391/
https://www.ncbi.nlm.nih.gov/pubmed/24975596
http://dx.doi.org/10.1111/cas.12474

Ejemplares similares